Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Synergistic Activity of Lysine Deacetylase Inhibitors and Microtubule-Targeting Agents in AML

James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Lisa Sproat, MD MSW, Jeanne Palmer, MD, Ruben Mesa, MD FACP, Raoul Tibes, MD PhD

Blood (2016) 128 (22): 3948.

https://doi.org/10.1182/blood.V128.22.3948.3948

Published: 2016

Journal Articles

Identification and Mechanistic Characterization of CMPD1 As a Selective Sensitizer of Histone Deacetylase Inhibitors in Myeloid Malignancies

James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Ruben A. Mesa, Raoul Tibes, MD

Blood (2015) 126 (23): 3689.

https://doi.org/10.1182/blood.V126.23.3689.3689

Published: 2015

Journal Articles

MK2a Substrate-Selective p38 Inhibitor CMPD1 Selectively Synergizes with HDAC Inhibitors in CD34 + Cells from Myeloid Malignancies

James M Bogenberger, PhD, Nanna Hansen, M.S., Devora Delman, B.S., Ruben A. Mesa, MD, Raoul Tibes, MD PhD

Blood (2014) 124 (21): 2239.

https://doi.org/10.1182/blood.V124.21.2239.2239

Published: 2014

Journal Articles

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

Giuseppe Visani, MD, Francesco Di Raimondo, MD, Felicetto Ferrara, MD, Federica Loscocco, Pier Paolo Piccaluga, Fabio Fuligni, Anna Gazzola, PhD, Maura Rossi, Antonella Laginestra, Maria Rita Caraci, Cira Riccardi, Axel Visani, Sara Barulli, Barbara Guiducci, Teresa Ricciardi, Giovanni Sparaventi, Marco Rocchi, Alessandro Isidori, MD, PhD

Blood (2013) 122 (21): 496.

https://doi.org/10.1182/blood.V122.21.496.496

Published: 2013

Journal Articles

LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY,

Giuseppe Visani, Felicetto Ferrara, MD, Francesco Di Raimondo, MD, Maria Rita Caraci, Tiziana Izzo, Sara Barulli, Barbara Guiducci, Federica Loscocco, Teresa Ricciardi, Giovanni Sparaventi, Alessandro Isidori, MD, PhD

Blood (2011) 118 (21): 3627.

https://doi.org/10.1182/blood.V118.21.3627.3627

Published: 2011

Journal Articles

Report on Response and Overall Survival of 128 Unselected, Consecutive AML Patients From the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group

Lisa Pleyer, MD, DI, Reinhard Stauder, MD, Sonja Burgstaller, MD, Martin Schreder, MD, Christoph Tinchon, MD, Michael Pfeilstocker, MD, Susanne Steinkirchner, MD, Thomas Melchardt, MD, Martina Mitrovic, Michael Girschikofsky, MD, Alois Lang, MD, Peter Krippl, MD, Thamer Sliwa, MD, Alexander Egle, MD, Werner Linkesch, MD, Michael A. Fridrik, MD, Richard Greil, MD

Blood (2011) 118 (21): 4266.

https://doi.org/10.1182/blood.V118.21.4266.4266

Published: 2011

Journal Articles

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Rafael Santana-Davila, MD, Shernan G. Holtan, MD, Rhett Ketterling, MD, Ryan A Knudson, David P. Steensma, MD, FACP, Dong Chen, MD, PhD, James Hoyer, MD, Curtis A Hanson, MD, Ayalew Tefferi, MD

Blood (2008) 112 (11): 2523.

https://doi.org/10.1182/blood.V112.11.2523.2523

Published: 2008

Journal Articles

Limited Efficacy of Hydroxyurea in Lowering of the JAK2 V617F Allele Burden.

Thomas Stauffer Larsen, Niels Pallisgaard, Karin de Stricker, Michael Boe Møller, Hans Carl Hasselbalch

Blood (2008) 112 (11): 1750.

https://doi.org/10.1182/blood.V112.11.1750.1750

Published: 2008

Journal Articles

Coincidence of JAK2V617F and BCR-ABL Is a Very Rare Event: Identification of 4 among 2317 Cases with Suspected CMPD.

Susanne Schnittger, PhD, Ulrike Bacher, MD, Claudia Haferlach, MD, Michael Flasshove, MD, Erik Engel, MD, Friedrich Ludwig, MD, Judith Franz-Werner, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2007) 110 (11): 2538.

https://doi.org/10.1182/blood.V110.11.2538.2538

Published: 2007

Journal Articles

Detection of JAK2 Exon 12 Mutations in 10 Patients (10.1%) of V617F Negative PV: A Study of 211 Cases with PV or Suspected PV.

Susanne Schnittger, PhD, Claudia Haferlach, MD, Thomas Geer, MD, Johann Mittermüller, MD, Pedro E. Petrides, MD, Rudolf Schlag, MD, Reiner Sandner, MD, Hans W. Tessen, MD, Jürgen Wehmeyer, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2007) 110 (11): 2541.

https://doi.org/10.1182/blood.V110.11.2541.2541

Published: 2007

Journal Articles

Detection of Three Different MPLW515 Mutations in 10.1% of All JAK2 V617 Unmutated ET and 9.3% of All JAK2 V617F Unmutated OMF: A Study of 387 Patients.

Susanne Schnittger, PhD, Claudia Haferlach, MD, Dietrich W. Beelen, MD, Peter Bojko, MD, Robert Dengler, MD, Andrea Diestelrath, MD, M.J. Eckart, MD, Robert Eckert, MD, Stefan Fries, MD, Georg Köchling, MD, Hans P. Laubenstein, MD, Manfred Planker, MD, Rudolf Pihusch, MD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2007) 110 (11): 2546.

https://doi.org/10.1182/blood.V110.11.2546.2546

Published: 2007

Journal Articles

Myelodysplastic Syndromes and Philadelphia Negative Chronic Myeloproliferative Diseases Show an Overlapping Pattern of Cytogenetic Aberrations.

Claudia Haferlach, MD, Susanne Schnittger, PhD, Wolfgang Kern, MD, Torsten Haferlach, MD

Blood (2007) 110 (11): 1553.

https://doi.org/10.1182/blood.V110.11.1553.1553

Published: 2007

Journal Articles

Relation between JAK2 V617F Mutation and Chronic Myeloproliferative Disorders.

Zhjian Xiao, MD, Yue Zhang, M.D., Jianxiang Wang, M.D., Yushu Hao, M.D.

Blood (2007) 110 (11): 4638.

https://doi.org/10.1182/blood.V110.11.4638.4638

Published: 2007

Journal Articles

Detection of the V617F Mutation of JAK2 Using a Novel Fully Automated SNP Super-Rapid Detector.

Ruriko Tanaka, Junya Kuroda, Eishi Ashihara, Takayuki Ishikawa, Tomohiko Taki, Mitsuharu Hirai, Satoshi Majima, Masafumi Taniwaki, Taira Maekawa, Shinya Kimura

Blood (2007) 110 (11): 4640.

https://doi.org/10.1182/blood.V110.11.4640.4640

Published: 2007

Journal Articles

Identification of a Novel TEL-Lyn Fusion Gene in Chronic Eosinophilic Leukemia with ins (12;8)(p13;q11q21): Effect on Myeloproliferative Transformation and Induction of Myelofibrosis.

Hiroaki Tanaka, MD, Masahiro Takeuchi, MD, Yusuke Takeda, MD, Kayo Oda, MD, Daijiro Abe, MD, Chikako Ohwada, MD, PhD, Shinichi Ozawa, MD, PhD, Emiko Sakaida, MD, PhD, Naomi Shimizu, MD, PhD, Ryuko Cho, MD, PhD, Miki Nishimura, MD, PhD, Yasushi Saito, MD, PhD, Satoru Miyagi, PhD, Atsushi Iwama, MD, PhD, Chiaki Nakaseko, MD, PhD

Blood (2007) 110 (11): 60.

https://doi.org/10.1182/blood.V110.11.60.60

Published: 2007

Journal Articles

A Molecular Cytogenetics Profile of Chromosome 9p in CMPD.

Beverley R. Vaughan, Diana Brazma, MD, Colin Grace, PhD, Julie Howard, Elisabeth Nacheva, MD, PhD

Blood (2007) 110 (11): 4659.

https://doi.org/10.1182/blood.V110.11.4659.4659

Published: 2007

Journal Articles

Development of a Novel Xenotransplantation System for Studying Human Acute Myeloid Leukemia.

Christopher Y. Park, MD, PhD, Ravindra Majeti, M.D., Ph.D., Brenton T. Tan, M.D., Ph.D., Irving L. Weissman, M.D.

Blood (2006) 108 (11): 1947.

https://doi.org/10.1182/blood.V108.11.1947.1947

Published: 2006

Journal Articles

Loss of JAK2 in CML Cell Lines.

Beverly Vaughan, Julie Howard, Diana Brazma, Elisabeth Nacheva, MD PhD FRCPath

Blood (2006) 108 (11): 4810.

https://doi.org/10.1182/blood.V108.11.4810.4810

Published: 2006

Journal Articles

JAK2V617F as a Cooperative Mutation in AML with Trisomy 8 and t(8;21): A Comparative Study on 271 AML and 1103 CMPD Cases.

Susanne Schnittger, PhD, Ulrike Bacher, MD, Wolfgang Kern, MD, Torsten Haferlach, MD, Claudia Schoch, MD

Blood (2006) 108 (11): 2063.

https://doi.org/10.1182/blood.V108.11.2063.2063

Published: 2006

Journal Articles

Plasma Adiponectin Concentrations in Relation to Chronic Lymphocytic Leukemia and Chronic Myeloproliferative Diseases.

Ferit Avcu, MD., Ali U. Ural, MD., Mahmut I. Yilmaz, MD., Necati Bingol, MD., Oral Nevruz, MD., Kayser Caglar, MD.

Blood (2004) 104 (11): 4743.

https://doi.org/10.1182/blood.V104.11.4743.4743

Published: 2004

NARROW

Synergistic Activity of Lysine Deacetylase Inhibitors and Microtubule-Targeting Agents in AML

Identification and Mechanistic Characterization of CMPD1 As a Selective Sensitizer of Histone Deacetylase Inhibitors in Myeloid Malignancies

MK2a Substrate-Selective p38 Inhibitor CMPD1 Selectively Synergizes with HDAC Inhibitors in CD34 + Cells from Myeloid Malignancies

Low-Dose Lenalidomide Plus Low Dose Cytarabine Induce Complete Remission That Can Be Predicted By Genetic Profiling In Very Elderly Acute Myeloid Leukemia Patients

LOW-DOSE LENALIDOMIDE COUPLED with LOW-DOSE Cytarabine INDUCES COMPLETE REMISSION of Elderly ACUTE Myeloid LEUKEMIA PATIENTS with Unfavorable Citogenetics: PRELIMINARY RESULTS of A PHASE II STUDY,

Report on Response and Overall Survival of 128 Unselected, Consecutive AML Patients From the Austrian Azacitidine Registry (AAR) of the AGMT-Study Group

Deletion 5q in AML: A Clinicopathological Description of 79 Cases from a Single Institution

Limited Efficacy of Hydroxyurea in Lowering of the JAK2 V617F Allele Burden.

Coincidence of JAK2V617F and BCR-ABL Is a Very Rare Event: Identification of 4 among 2317 Cases with Suspected CMPD.

Detection of JAK2 Exon 12 Mutations in 10 Patients (10.1%) of V617F Negative PV: A Study of 211 Cases with PV or Suspected PV.

Detection of Three Different MPLW515 Mutations in 10.1% of All JAK2 V617 Unmutated ET and 9.3% of All JAK2 V617F Unmutated OMF: A Study of 387 Patients.

Myelodysplastic Syndromes and Philadelphia Negative Chronic Myeloproliferative Diseases Show an Overlapping Pattern of Cytogenetic Aberrations.

Relation between JAK2 V617F Mutation and Chronic Myeloproliferative Disorders.

Detection of the V617F Mutation of JAK2 Using a Novel Fully Automated SNP Super-Rapid Detector.

Identification of a Novel TEL-Lyn Fusion Gene in Chronic Eosinophilic Leukemia with ins (12;8)(p13;q11q21): Effect on Myeloproliferative Transformation and Induction of Myelofibrosis.

A Molecular Cytogenetics Profile of Chromosome 9p in CMPD.

Development of a Novel Xenotransplantation System for Studying Human Acute Myeloid Leukemia.

Loss of JAK2 in CML Cell Lines.

JAK2V617F as a Cooperative Mutation in AML with Trisomy 8 and t(8;21): A Comparative Study on 271 AML and 1103 CMPD Cases.

Plasma Adiponectin Concentrations in Relation to Chronic Lymphocytic Leukemia and Chronic Myeloproliferative Diseases.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only